Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Preterminal host dendritic cells in irradiated mice prime CD8+ T cell–mediated acute graft-versus-host disease
Yi Zhang, Jean-Pierre Louboutin, Jiang Zhu, Adam J. Rivera, Stephen G. Emerson
Yi Zhang, Jean-Pierre Louboutin, Jiang Zhu, Adam J. Rivera, Stephen G. Emerson
View: Text | PDF
Article Immunology

Preterminal host dendritic cells in irradiated mice prime CD8+ T cell–mediated acute graft-versus-host disease

  • Text
  • PDF
Abstract

To understand the relationship between host antigen-presenting cells (APCs) and donor T cells in initiating graft-versus-host disease (GVHD), we followed the fate of host dendritic cells (DCs) in irradiated C57BL/6 (B6) recipient mice and the interaction of these cells with minor histocompatibility antigen- (miHA-) mismatched CD8+ T cells from C3H.SW donors. Host CD11c+ DCs were rapidly activated and aggregated in the T cell areas of the spleen within 6 hours of lethal irradiation. By 5 days after irradiation, <1% of host DCs were detectable, but the activated donor CD8+ T cells had already undergone as many as seven divisions. Thus, proliferation of donor CD8+ T cells preceded the disappearance of host DCs. When C3H.SW donor CD8+ T cells were primed in vivo in irradiated B6 mice or ex vivo by host CD11c+ DCs for 24–36 hours, they were able to proliferate and differentiate into IFN-γ–producing cells in β2-microglobulin–deficient (β2m–/–) B6 recipients and to mediate acute GVHD in β2m–/– → B6 chimeric mice. These results indicate that, although host DCs disappear rapidly after allogeneic bone marrow transplantation, they prime donor T cells before their disappearance and play a critical role in triggering donor CD8+ T cell–mediated GVHD.

Authors

Yi Zhang, Jean-Pierre Louboutin, Jiang Zhu, Adam J. Rivera, Stephen G. Emerson

×

Figure 7

Options: View larger image (or click on image) Download as PowerPoint
Brief priming by host DCs triggers the committed differentiation of dono...
Brief priming by host DCs triggers the committed differentiation of donor naive CD8+ T cells into effectors. (a) Naive C3H.SW CFSE-CD8+ T cells were intravenously injected into lethally irradiated B6/SJL (CD45.1+) mice. After 24 to 36 hours, these primed C3H.SW CFSE-CD8+ T cells were then purified and adoptively transferred into secondary irradiated β2m–/– recipient mice. Six days later, cells from the spleens and lymph nodes of secondary recipients were cultured in the presence or absence of CD3 Ab plus MC57SV cells irradiated with 30 Gy for measuring IFN-γ production as described in Methods. Dot plots shown represent IFN-γ and CFSE intensity measured in gated CD8+ T cells. Naive unprimed C3H.SW CFSE-CD8+ T cells were injected into lethally irradiated B6/SJL mice (CD45.1+) and β2m–/– mice as control. (b) C3H.SW CFSE-CD8+ T cells were stimulated ex vivo by host CD11c+ DCs for 24 hours, recovered, sorted, and adoptively transferred into irradiated β2m–/– mice. Six days later, cells from spleens and lymph nodes were separated from the secondary recipients and stained with anti-CD8 Ab for measuring donor CD8+ T cell divisions. These cells were also cultured for 16 hours as described in a, to measure IFN-γ secretion. (c) Survival rate of β2m–/– B6 → B6 BM chimeric mice that received either C3H.SW T–BM alone, C3H.SW T–BM + C3H.SW CD8+ T cells, or C3H.SW T–BM + C3H.SW CD8+ T cells that were primed ex vivo by B6 CD11c+ DCs. Representative results from two independent experiments are shown.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts